MEG/MRS Dose Response Study of STX209 in ASD
Project Description:
Pilot study investigating the effect of escalating doses of Arbaclofen (STX209) on MEG/MRS in children with ASD.
Core Function(s):
Training Trainees, Continuing Education/Community Training
Area of Emphasis
Education & Early Intervention, Child Care-Related Activities
Target Audience:
Students/Trainees (long or intermediate trainees), Community Trainees / Short term trainees, Professionals and Para-Professionals
Unserved or Under-served Populations:
Racial or Ethnic Minorities, Disadvantaged Circumstances, Limited English
Primary Target Audience Geographic Descriptor:
Single-County, State
COVID-19 Related Data:
N/A